Your browser doesn't support javascript.
loading
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
Rein, Sophia M; Lodi, Sara; Logan, Roger W; Touloumi, Giota; Antoniadou, Anastasia; Wittkop, Linda; Bonnet, Fabrice; van Sighem, Ard; van der Valk, Marc; Reiss, Peter; Klein, Marina B; Young, James; Jarrin, Inmaculada; d'Arminio Monforte, Antonella; Tavelli, Alessandro; Meyer, Laurence; Tran, Laurent; Gill, Michael J; Lang, Raynell; Surial, Bernard; Haas, Andreas D; Justice, Amy C; Rentsch, Christopher T; Phillips, Andrew; Sabin, Caroline A; Miro, Jose M; Trickey, Adam; Ingle, Suzanne M; Sterne, Jonathan A C; Hernán, Miguel A.
Afiliação
  • Rein SM; CAUSALab and Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA. Electronic address: srein@hsph.harvard.edu.
  • Lodi S; CAUSALab and Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Logan RW; CAUSALab and Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Touloumi G; Department of Hygiene, Epidemiology, & Medical Statistics, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Antoniadou A; 4th Department of Internal Medicine, Attikon University General Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Wittkop L; University of Bordeaux, INSERM, Bordeaux Population Health-U1219, CIC1401-EC, Bordeaux, France; SISTM, INRIA, Talence, France; CHU de Bordeaux, Bordeaux University Hospital, Service d'information médicale, INSERM, CIC-EC 1401, Bordeaux, France.
  • Bonnet F; University of Bordeaux, INSERM, Bordeaux Population Health-U1219, CIC1401-EC, Bordeaux, France; CHU de Bordeaux, Bordeaux University Hospital, Service d'information médicale, INSERM, CIC-EC 1401, Bordeaux, France.
  • van Sighem A; Stichting HIV Monitoring, Amsterdam, Netherlands.
  • van der Valk M; Stichting HIV Monitoring, Amsterdam, Netherlands; Amsterdam UMC, Department of Infectious Diseases, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
  • Reiss P; Department of Global Health, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
  • Klein MB; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
  • Young J; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
  • Jarrin I; Centro Nacional de Epidemiologia, Institute of Health Carlos III, Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • d'Arminio Monforte A; Icona Foundation, Milan, Italy.
  • Tavelli A; Icona Foundation, Milan, Italy.
  • Meyer L; INSERM U1018, Université Paris Saclay, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Le Kremlin-Bicêtre, France; Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Service de Santé Publique, Hôpital Bicêtr, Le Kremlin-Bicêtre, France.
  • Tran L; INSERM U1018, Université Paris Saclay, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Le Kremlin-Bicêtre, France.
  • Gill MJ; Southern Alberta Clinic and Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Lang R; Southern Alberta Clinic and Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Surial B; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Haas AD; Institute of Social & Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Justice AC; Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA; Department of Health Policy, Yale School of Public Health, Yale University, New Haven, CT, USA; VA Connecticut Healthcare System, US Department of Veterans Affairs, New Haven, Connecticut, USA.
  • Rentsch CT; Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA; VA Connecticut Healthcare System, US Department of Veterans Affairs, New Haven, Connecticut, USA; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK
  • Phillips A; Institute for Global Health, University College London, London, UK.
  • Sabin CA; Institute for Global Health, University College London, London, UK.
  • Miro JM; Infectious Diseases Service, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • Trickey A; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Ingle SM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK; Health Data Research UK South-West, Bristol, UK.
  • Hernán MA; CAUSALab and Department of Epidemiology, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA; Department of Biostatistics, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.
Lancet HIV ; 10(11): e723-e732, 2023 11.
Article em En | MEDLINE | ID: mdl-37923486

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Infecções por HIV / Inibidores de Integrase de HIV Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Revista: Lancet HIV Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Infecções por HIV / Inibidores de Integrase de HIV Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Revista: Lancet HIV Ano de publicação: 2023 Tipo de documento: Article